DailyFinance  Mar 3  Comment 
TORONTO, ONTARIO and NEW YORK, NEW YORK -- (Marketwired) -- 03/03/14 -- iSIGN Media Solutions Inc. ("iSIGN" or "Company") (TSX VENTURE: ISD)(OTCQX: ISDSF), a leading provider of interactive mobile advertising solutions that serves advertisers,...
The Globe and Mail  Aug 29  Comment 
Pharmaceutical company sets the shareholder-approval vote for October 5
Reuters  Aug 29  Comment 
A Quebec court authorized Labopharm Inc to hold a special meeting of shareholders for the approval of the Canadian biotech firm's acquisition by Paladin Labs .
Penny Stock DD  Aug 18  Comment 
Labopharm Inc., (DDS-T0.280.1061.76%) a once high-flying Montreal drug company with a share price to match., has reached the end of the road with a agreement to be taken over by Paladin Labs Inc. (PLB-T40.950.461.14%) The agreement will see...
Penny Stock DD  Aug 17  Comment 
Drug company Paladin Labs Inc. (TSX:PLB) announced Wednesday that it plans to acquire Labopharm Inc. in a friendly deal that values the fellow Quebec company at more than $20 million. Paladin, which earlier this month announced a hostile bid...
FierceBiotech  Aug 17  Comment 
Paladin Labs has struck a deal to buy Labopharm in a deal that values the biotech at a bit more than $20 million. Paladin is paying 28.5 cents a share, a significant premium over the bargain basement price of 18 cents a share Labopharm had been...
The Globe and Mail  Jul 18  Comment 
Move reduces workforce to 71 in bid to cut costs
Benzinga  Jun 21  Comment 
Labopharm Inc. (NASDAQ: DDSS) announced today its intention to delist its common shares from The Nasdaq Global Market as of the close of business on June 30, 2011. The Company's common shares will continue to be listed on the Toronto Stock...
FierceBiotech  Apr 29  Comment 
Labopharm said today that it's reviewing options for its assets, technologies and products and considering "potential business combinations that could create value for shareholders." The Canadian company revealed in March that it was undertaking...
Reuters  Apr 29  Comment 
Canadian biotechnology firm Labopharm Inc said on Friday it was looking at various options for its assets and products, as well as exploring potential business...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki